metformin and Lymphohistiocytosis, Hemophagocytic
metformin has been researched along with Lymphohistiocytosis, Hemophagocytic in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Lymphohistiocytosis, Hemophagocytic: A group of related disorders characterized by LYMPHOCYTOSIS; HISTIOCYTOSIS; and hemophagocytosis. The two major forms are familial and reactive.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ramírez-Bellver, JL | 1 |
Lopez, J | 1 |
Macias, E | 1 |
Fuertes, L | 1 |
Andres, I | 1 |
Alegria, V | 1 |
Gimeno, I | 1 |
Perez, A | 1 |
Perez, Y | 1 |
Requena, L | 1 |
Other Studies
1 other study available for metformin and Lymphohistiocytosis, Hemophagocytic
Article | Year |
---|---|
Metformin-Induced Generalized Fixed Drug Eruption With Cutaneous Hemophagocytosis.
Topics: Aged, 80 and over; Biopsy; Diabetes Mellitus, Type 2; Drug Eruptions; Drug Substitution; Histiocytes | 2017 |